Bacuyong, Juanito, Jr. S.
HRN: 21-95-36 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/20/2022
10/28/2022
IV
2.25gms
Q6
Empirical Escalation
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes